XML 23 R10.htm IDEA: XBRL DOCUMENT v3.3.1.900
INVESTMENTS
12 Months Ended
Dec. 31, 2015
Investments, Debt and Equity Securities [Abstract]  
Investments
INVESTMENTS
Fixed Maturities and Equity Securities
The following table provides information relating to fixed maturities and equity securities classified as AFS:
Available-for-Sale Securities by Classification
 
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair Value    
 
OTTI
in AOCI(3)
 
 
 
 
 
(In Millions)
 
 
 
 
December 31, 2015
 
 
 
 
 
 
 
 
 
Fixed Maturity Securities:
 
 
 
 
 
 
 
 
 
Public corporate
$
12,890

 
$
688

 
$
202

 
$
13,376

 
$

Private corporate
6,818

 
232

 
124

 
6,926

 

U.S. Treasury, government and agency
8,800

 
280

 
305

 
8,775

 

States and political subdivisions
437

 
68

 
1

 
504

 

Foreign governments
397

 
36

 
18

 
415

 

Commercial mortgage-backed
591

 
29

 
87

 
533

 
9

Residential mortgage-backed(1)
608

 
32

 

 
640

 

Asset-backed(2)
68

 
10

 
1

 
77

 
3

Redeemable preferred stock
592

 
57

 
2

 
647

 

Total Fixed Maturities
31,201

 
1,432

 
740

 
31,893

 
12

Equity securities
34

 

 
2

 
32

 

Total at December 31, 2015
$
31,235

 
$
1,432

 
$
742

 
$
31,925

 
$
12

December 31, 2014:
 
 
 
 
 
 
 
 
 
Fixed Maturity Securities:
 
 
 
 
 
 
 
 
 
Public corporate
$
13,808

 
$
1,140

 
$
51

 
$
14,897

 
$

Private corporate
6,934

 
409

 
20

 
7,323

 

U.S. Treasury, government and agency
6,685

 
672

 
26

 
7,331

 

States and political subdivisions
441

 
78

 

 
519

 

Foreign governments
405

 
48

 
7

 
446

 

Commercial mortgage-backed
855

 
22

 
142

 
735

 
10

Residential mortgage-backed(1)
752

 
43

 

 
795

 

Asset-backed(2)
86

 
14

 
1

 
99

 
3

Redeemable preferred stock
829

 
70

 
10

 
889

 

Total Fixed Maturities
30,795

 
2,496

 
257

 
33,034

 
13

Equity securities
36

 
2

 

 
38

 

Total at December 31, 2014
$
30,831

 
$
2,498

 
$
257

 
$
33,072

 
$
13

(1)
Includes publicly traded agency pass-through securities and collateralized mortgage obligations.
(2)
Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.
(3)
Amounts represent OTTI losses in AOCI, which were not included in earnings (loss) in accordance with current accounting guidance.
The contractual maturities of AFS fixed maturities (excluding redeemable preferred stock) at December 31, 2015 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
Available-for-Sale Fixed Maturities
Contractual Maturities at December 31, 2015
 
Amortized Cost
 
Fair Value
 
 
(In Millions)
Due in one year or less
$
1,469

 
$
1,486

Due in years two through five
7,012

 
7,395

Due in years six through ten
10,429

 
10,406

Due after ten years
10,432

 
10,709

Subtotal
29,342

 
29,996

Commercial mortgage-backed securities
591

 
533

Residential mortgage-backed securities
608

 
640

Asset-backed securities
68

 
77

Total
$
30,609

 
$
31,246


The following table shows proceeds from sales, gross gains (losses) from sales and OTTI for AFS fixed maturities during 2015, 2014 and 2013:
 
December 31,
 
2015
 
2014
 
2013
 
 
(In Millions)
Proceeds from sales
$
979

 
$
716

 
$
3,220

Gross gains on sales
$
33

 
$
21

 
$
71

Gross losses on sales
$
(8
)
 
$
(9
)
 
$
(88
)
Total OTTI
$
(41
)
 
$
(72
)
 
$
(81
)
Non-credit losses recognized in OCI

 

 
15

Credit losses recognized in earnings (loss)
$
(41
)
 
$
(72
)
 
$
(66
)

The following table sets forth the amount of credit loss impairments on fixed maturity securities held by the Company at the dates indicated and the corresponding changes in such amounts.
Fixed Maturities - Credit Loss Impairments
 
2015
 
2014
 
(In Millions)
Balances at January 1,
$
(254
)
 
$
(370
)
Previously recognized impairments on securities that matured, paid, prepaid or sold
97

 
188

Recognized impairments on securities impaired to fair value this period(1)
(11
)
 

Impairments recognized this period on securities not previously impaired
(22
)
 
(41
)
Additional impairments this period on securities previously impaired
(8
)
 
(31
)
Increases due to passage of time on previously recorded credit losses

 

Accretion of previously recognized impairments due to increases in expected cash flows

 

Balances at December 31,
$
(198
)
 
$
(254
)

(1)
Represents circumstances where the Company determined in the current period that it intends to sell the security or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost.
Net unrealized investment gains (losses) on fixed maturities and equity securities classified as AFS are included in the consolidated balance sheets as a component of AOCI. The table below presents these amounts as of the dates indicated:

 
December 31,
 
2015
 
2014
 
(In Millions)
AFS Securities:
 
 
 
Fixed maturities:
 
 
 
With OTTI loss
$
16

 
$
10

All other
676

 
2,229

Equity securities
(2
)
 
2

Net Unrealized Gains (Losses)
$
690

 
$
2,241


Changes in net unrealized investment gains (losses) recognized in AOCI include reclassification adjustments to reflect amounts realized in Net earnings (loss) for the current period that had been part of OCI in earlier periods. The tables that follow below present a rollforward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturity securities on which an OTTI loss has been recognized, and all other:
Net Unrealized Gains (Losses) on Fixed Maturities with OTTI Losses
 
Net
Unrealized
Gain
(Losses) on
Investments
 
DAC
 
Policyholders
Liabilities
 
Deferred
Income
Tax Asset
(Liability)
 
AOCI Gain
(Loss) Related
to Net
Unrealized
Investment
Gains (Losses)  
 
(In Millions)
Balance, January 1, 2015
$
10

 
$

 
$

 
$
(4
)
 
$
6

Net investment gains (losses) arising
    during the period
(7
)
 

 

 

 
(7
)
Reclassification adjustment for OTTI losses:
 
 
 
 
 
 
 
 
 
Included in Net earnings (loss)
13

 

 

 

 
13

Excluded from Net earnings (loss)(1)

 

 

 

 

Impact of net unrealized investment gains (losses) on:
 
 
 
 
 
 
 
 
 
DAC

 

 

 

 

Deferred income taxes

 

 

 
(1
)
 
(1
)
Policyholders liabilities

 

 
(4
)
 

 
(4
)
Balance, December 31, 2015
$
16

 
$

 
$
(4
)
 
$
(5
)
 
$
7

Balance, January 1, 2014
$
(28
)
 
$
2

 
$
10

 
$
5

 
$
(11
)
Net investment gains (losses) arising during the period
(1
)
 

 

 

 
(1
)
Reclassification adjustment for OTTI losses:
 
 
 
 
 
 
 
 
 
Included in Net earnings (loss)
39

 

 

 

 
39

Excluded from Net earnings (loss)(1)

 

 

 

 

Impact of net unrealized investment gains (losses) on:
 
 
 
 
 
 
 
 
 
DAC

 
(2
)
 

 

 
(2
)
Deferred income taxes

 

 

 
(9
)
 
(9
)
Policyholders liabilities

 

 
(10
)
 

 
(10
)
Balance, December 31, 2014
$
10

 
$

 
$

 
$
(4
)
 
$
6



(1)
Represents “transfers in” related to the portion of OTTI losses recognized during the period that were not recognized in earnings (loss) for securities with no prior OTTI loss.
All Other Net Unrealized Investment Gains (Losses) in AOCI
 
Net
Unrealized
Gains
(Losses) on
Investments
 
DAC  
 
Policyholders  
Liabilities
 
Deferred
Income
Tax Asset
(Liability)
 
AOCI Gain
(Loss) Related
to Net
Unrealized
Investment
  Gains (Losses)  
 
(In Millions)
Balance, January 1, 2015
$
2,231

 
$
(122
)
 
$
(368
)
 
$
(610
)
 
$
1,131

Net investment gains (losses) arising during the period
(1,562
)
 

 

 

 
(1,562
)
Reclassification adjustment for OTTI losses:
 
 
 
 
 
 
 
 
 
Included in Net earnings (loss)
5

 

 

 

 
5

Excluded from Net earnings (loss)(1)

 

 

 

 

Impact of net unrealized investment gains (losses) on:
 
 
 
 
 
 
 
 
 
DAC

 
40

 

 

 
40

Deferred income taxes

 

 

 
477

 
477

Policyholders liabilities

 

 
155

 

 
155

Balance, December 31, 2015
$
674

 
$
(82
)
 
$
(213
)
 
$
(133
)
 
$
246

Balance, January 1, 2014
$
607

 
$
(107
)
 
$
(245
)
 
$
(90
)
 
$
165

Net investment gains (losses) arising during the period
1,606

 

 

 

 
1,606

Reclassification adjustment for OTTI losses:
 
 
 
 
 
 
 
 
 
Included in Net earnings (loss)
18

 

 

 

 
18

Excluded from Net earnings (loss)(1)

 

 

 

 

Impact of net unrealized investment gains (losses) on:
 
 
 
 
 
 
 
 
 
DAC

 
(15
)
 

 

 
(15
)
Deferred income taxes

 

 

 
(520
)
 
(520
)
Policyholders liabilities

 

 
(123
)
 

 
(123
)
Balance, December 31, 2014
$
2,231

 
$
(122
)
 
$
(368
)
 
$
(610
)
 
$
1,131


(1)
Represents “transfers out” related to the portion of OTTI losses during the period that were not recognized in earnings (loss) for securities with no prior OTTI loss.
The following tables disclose the fair values and gross unrealized losses of the 810 issues at December 31, 2015 and the 601 issues at December 31, 2014 of fixed maturities that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated:
 
Less Than 12 Months
 
12 Months or Longer
 
Total
 
Fair Value 
 
Gross
Unrealized 
Losses
 
Fair Value 
 
Gross
Unrealized 
Losses
 
Fair Value 
 
Gross
Unrealized
Losses
 
(In Millions)
December 31, 2015:
 
 
 
 
 
 
 
 
 
 
 
Fixed Maturity Securities:
 
 
 
 
 
 
 
 
 
 
 
Public corporate
$
3,091

 
$
129

 
$
359

 
$
73

 
$
3,450

 
$
202

Private corporate
1,926

 
102

 
184

 
22

 
2,110

 
124

U.S. Treasury, government and agency
3,538

 
305

 

 

 
3,538

 
305

States and political subdivisions
19

 
1

 

 

 
19

 
1

Foreign governments
73

 
7

 
39

 
11

 
112

 
18

Commercial mortgage-backed
67

 
2

 
261

 
85

 
328

 
87

Residential mortgage-backed
11

 

 
29

 

 
40

 

Asset-backed
11

 

 
17

 
1

 
28

 
1

Redeemable preferred stock
43

 

 
40

 
2

 
83

 
2

Total
$
8,779

 
$
546

 
$
929

 
$
194

 
$
9,708

 
$
740

December 31, 2014:
 
 
 
 
 
 
 
 
 
 
 
Fixed Maturity Securities:
 
 
 
 
 
 
 
 
 
 
 
Public corporate
$
687

 
$
18

 
$
794

 
$
33

 
$
1,481

 
$
51

Private corporate
627

 
11

 
254

 
9

 
881

 
20

U.S. Treasury, government and agency
280

 
6

 
373

 
20

 
653

 
26

States and political subdivisions
21

 

 

 

 
21

 

Foreign governments
27

 
1

 
65

 
6

 
92

 
7

Commercial mortgage-backed
37

 
2

 
355

 
140

 
392

 
142

Residential mortgage-backed

 

 
35

 

 
35

 

Asset-backed

 

 
20

 
1

 
20

 
1

Redeemable preferred stock
42

 

 
169

 
10

 
211

 
10

Total
$
1,721

 
$
38

 
$
2,065

 
$
219

 
$
3,786

 
$
257


The Company’s investments in fixed maturity securities do not include concentrations of credit risk of any single issuer greater than 10% of the consolidated equity of AXA Equitable, other than securities of the U.S. government, U.S. government agencies, and certain securities guaranteed by the U.S. government. The Company maintains a diversified portfolio of corporate securities across industries and issuers and does not have exposure to any single issuer in excess of 0.3% of total investments. The largest exposures to a single issuer of corporate securities held at December 31, 2015 and 2014 were $157 million and $146 million, respectively. Corporate high yield securities, consisting primarily of public high yield bonds, are classified as other than investment grade by the various rating agencies, i.e., a rating below Baa3/BBB- or the National Association of Insurance Commissioners (“NAIC”) designation of 3 (medium grade), 4 or 5 (below investment grade) or 6 (in or near default). At December 31, 2015 and 2014, respectively, approximately $1,310 million and $1,788 million, or 4.2% and 5.8%, of the $31,201 million and $30,795 million aggregate amortized cost of fixed maturities held by the Company were considered to be other than investment grade. These securities had net unrealized losses of $97 million and $85 million at December 31, 2015 and 2014, respectively. At December 31, 2015 and 2014, respectively, the $194 million and $219 million of gross unrealized losses of twelve months or more were concentrated in corporate and commercial mortgage-backed securities. In accordance with the policy described in Note 2, the Company concluded that an adjustment to earnings for OTTI for these securities was not warranted at either December 31, 2015 or 2014. As of December 31, 2015, the Company did not intend to sell the securities nor will it likely be required to dispose of the securities before the anticipated recovery of their remaining amortized cost basis.
The Company does not originate, purchase or warehouse residential mortgages and is not in the mortgage servicing business. The Company’s fixed maturity investment portfolio includes residential mortgage backed securities (“RMBS”) backed by subprime and Alt-A residential mortgages, comprised of loans made by banks or mortgage lenders to residential borrowers with lower credit ratings. The criteria used to categorize such subprime borrowers include Fair Isaac Credit Organization (“FICO”) scores, interest rates charged, debt-to-income ratios and loan-to-value ratios. Alt-A residential mortgages are mortgage loans where the risk profile falls between prime and subprime; borrowers typically have clean credit histories but the mortgage loan has an increased risk profile due to higher loan-to-value and debt-to-income ratios and/or inadequate documentation of the borrowers’ income. At December 31, 2015 and 2014, respectively, the Company owned $7 million and $8 million in RMBS backed by subprime residential mortgage loans, and $6 million and $7 million in RMBS backed by Alt-A residential mortgage loans. RMBS backed by subprime and Alt-A residential mortgages are fixed income investments supporting General Account liabilities.
At December 31, 2015, the carrying value of fixed maturities that were non-income producing for the twelve months preceding that date was $8 million.
At December 31, 2015 and 2014, respectively, the amortized cost of the Company’s trading account securities was $6,866 million and $5,160 million with respective fair values of $6,805 million and $5,143 million. Also at December 31, 2015 and 2014, respectively, Other equity investments included the General Account’s investment in Separate Accounts which had carrying values of $82 million and $197 million and costs of $72 million and $185 million as well as other equity securities with carrying values of $32 million and $38 million and costs of $34 million and $36 million.
Net unrealized and realized gains (losses) on trading account equity securities are included in Net investment income (loss) in the consolidated statements of earnings (loss). The table below shows a breakdown of Net investment income from trading account securities during the year ended 2015 and 2014:

Net Investment Income (Loss) from Trading Securities
 
Twelve Months Ended
 
December 31,
2015
 
December 31,
2014
 
(In Millions)
Net investment gains (losses) recognized during the period on securities held at the end of the period
$
(63
)
 
$

Net investment gains (losses) recognized on securities sold during the period
20

 
22

Unrealized and realized gains (losses) on trading securities
(43
)
 
22

Interest and dividend income from trading securities
60

 
41

Net investment income (loss) from trading securities
$
17

 
$
63


Mortgage Loans
The payment terms of mortgage loans may from time to time be restructured or modified.
Troubled Debt Restructurings
The investment in troubled debt restructured mortgage loans, based on amortized cost, amounted to $16 million and $93 million at December 31, 2015 and 2014, respectively. Gross interest income on these loans included in net investment income (loss) totaled $1 million, $1 million and $2 million in 2015, 2014 and 2013, respectively. Gross interest income on restructured mortgage loans that would have been recorded in accordance with the original terms of such loans amounted to $0 million, $4 million and $7 million in 2015, 2014 and 2013, respectively. The TDR mortgage loan shown in the table below has been modified four times since 2011. The modifications were to extend the maturity from its original maturity of November 5, 2014 to December 5, 2016 and to extend interest only payments through maturity. In November 2015, the recorded investment was reduced by $45 million in conjunction with the sale of majority of the underlying collateral and $32 million from a charge-off. The remaining $16 million mortgage loan balance reflects the value of the remaining underlying collateral and cash held in escrow, supporting the mortgage loan. Since the fair market value of the underlying real estate and cash held in escrow collateral is the primary factor in determining the allowance for credit losses, modifications of loan terms typically have no direct impact on the allowance for credit losses, and therefore, no impact on the financial statements.
Troubled Debt Restructuring - Modifications
December 31, 2015
 
Number
 
Outstanding Recorded Investment
 
of Loans  
 
Pre-Modification    
 
Post - Modification    
 
 
 
(Dollars In Millions)
Commercial mortgage loans
1

 
$
16

 
$
16


There were no default payments on the above loan during 2015. There were no agricultural troubled debt restructuring mortgage loans in 2015.
Valuation Allowances for Mortgage Loans:
Allowance for credit losses for mortgage loans for 2015, 2014 and 2013 are as follows:
 
Commercial Mortgage Loans
 
2015
 
2014
 
2013
Allowance for credit losses:
(In Millions)
Beginning Balance, January 1,
$
37

 
$
42

 
$
34

Charge-offs
(32
)
 
(14
)
 

Recoveries
(1
)
 

 
(2
)
Provision
2

 
9

 
10

Ending Balance, December 31,
$
6

 
$
37

 
$
42

Ending Balance, December 31,:
 
 
 
 
 
Individually Evaluated for Impairment
$
6

 
$
37

 
$
42


There were no allowances for credit losses for agricultural mortgage loans in 2015, 2014 and 2013.
The following tables provide information relating to the loan-to-value and debt service coverage ratios for commercial and agricultural mortgage loans at December 31, 2015 and 2014, respectively. The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value.
Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios
December 31, 2015
 
Debt Service Coverage Ratio
 
 
Loan-to-Value Ratio:(2)
Greater
than 
2.0x
 
1.8x to
2.0x
 
1.5x to
1.8x
 
1.2x to
1.5x
 
1.0x to
1.2x
 
Less than
1.0x
 
Total
Mortgage
Loans
 
(In Millions)
Commercial Mortgage Loans(1)
 
 
 
 
 
 
 
 
 
 
 
 
 
0% - 50%
$
533

 
$

 
$
102

 
$
12

 
$
24

 
$

 
$
671

50% - 70%
1,392

 
353

 
741

 
853

 
77

 

 
3,416

70% - 90%
141

 

 
206

 
134

 
124

 
46

 
651

90% plus
63

 

 

 
46

 

 

 
109

Total Commercial Mortgage Loans
$
2,129

 
$
353

 
$
1,049

 
$
1,045

 
$
225

 
$
46

 
$
4,847

Agricultural Mortgage Loans(1)
 
 
 
 
 
 
 
 
 
 
 
 
 
0% - 50%
$
204

 
$
116

 
$
277

 
$
432

 
$
256

 
$
51

 
$
1,336

50% - 70%
146

 
80

 
192

 
298

 
225

 
47

 
988

70% - 90%

 

 
2

 
4

 

 

 
6

90% plus

 

 

 

 

 

 

Total Agricultural Mortgage Loans
$
350

 
$
196

 
$
471

 
$
734

 
$
481

 
$
98

 
$
2,330

Total Mortgage Loans(1)
 
 
 
 
 
 
 
 
 
 
 
 
 
0% - 50%
$
737

 
$
116

 
$
379

 
$
444

 
$
280

 
$
51

 
$
2,007

50% - 70%
1,538

 
433

 
933

 
1,151

 
302

 
47

 
4,404

70% - 90%
141

 

 
208

 
138

 
124

 
46

 
657

90% plus
63

 

 

 
46

 

 

 
109

Total Mortgage Loans
$
2,479

 
$
549

 
$
1,520

 
$
1,779

 
$
706

 
$
144

 
$
7,177

(1)
The debt service coverage ratio is calculated using the most recently reported net operating income results from property operations divided by annual debt service.
(2)
The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually.
Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios
December 31, 2014
 
Debt Service Coverage Ratio
 
 
Loan-to-Value Ratio:(2)
Greater
than
2.0x
 
1.8x to
2.0x
 
1.5x to
1.8x
 
1.2x to
1.5x
 
1.0x to
1.2x
 
Less than
1.0x
 
Total
Mortgage
Loans
 
(In Millions)
Commercial Mortgage Loans(1)
 
 
 
 
 
 
 
 
 
 
 
 
 
0% - 50%
$
335

 
$

 
$

 
$
59

 
$
34

 
$

 
$
428

50% - 70%
963

 
440

 
872

 
839

 
54

 

 
3,168

70% - 90%
211

 

 
61

 
265

 
79

 

 
616

90% plus
156

 

 

 

 

 
47

 
203

Total Commercial Mortgage Loans
$
1,665

 
$
440

 
$
933

 
$
1,163

 
$
167

 
$
47

 
$
4,415

Agricultural Mortgage Loans(1)
 
 
 
 
 
 
 
 
 
 
 
 
 
0% - 50%
$
184

 
$
100

 
$
232

 
$
408

 
$
206

 
$
50

 
$
1,180

50% - 70%
143

 
87

 
201

 
223

 
204

 
47

 
905

70% - 90%

 

 

 

 

 

 

90% plus

 

 

 

 

 

 

Total Agricultural Mortgage Loans
$
327

 
$
187

 
$
433

 
$
631

 
$
410

 
$
97

 
$
2,085

Total Mortgage Loans(1)
 
 
 
 
 
 
 
 
 
 
 
 
 
0% - 50%
$
519

 
$
100

 
$
232

 
$
467

 
$
240

 
$
50

 
$
1,608

50% - 70%
1,106

 
527

 
1,073

 
1,062

 
258

 
47

 
4,073

70% - 90%
211

 

 
61

 
265

 
79

 

 
616

90% plus
156

 

 

 

 

 
47

 
203

Total Mortgage Loans
$
1,992

 
$
627

 
$
1,366

 
$
1,794

 
$
577

 
$
144

 
$
6,500


(1)
The debt service coverage ratio is calculated using the most recently reported net operating income results from property operations divided by annual debt service.
(2)
The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually.
The following table provides information relating to the aging analysis of past due mortgage loans at December 31, 2015 and 2014, respectively.
Age Analysis of Past Due Mortgage Loan
 
30-59 Days
 
60-89
Days
 
90
Days
Or >
 
Total
 
Current
 
Total
Financing
Receivables
 
Recorded
Investment
> 90 Days
and
Accruing
 
(In Millions)
December 31, 2015:
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial
$

 
$

 
$
30

 
$
30

 
$
4,817

 
$
4,847

 
$

Agricultural
12

 
7

 
4

 
23

 
2,307

 
2,330

 
4

Total Mortgage Loans
$
12

 
$
7

 
$
34

 
$
53

 
$
7,124

 
$
7,177

 
$
4

December 31, 2014:
 
 
 
 
 
 
 
 
 
 
 
 
 
Commercial
$

 
$

 
$

 
$

 
$
4,415

 
$
4,415

 
$

Agricultural
1

 
7

 
3

 
11

 
2,074

 
2,085

 
3

Total Mortgage Loans
$
1

 
$
7

 
$
3

 
$
11

 
$
6,489

 
$
6,500

 
$
3


The following table provides information relating to impaired mortgage loans at December 31, 2015 and 2014, respectively.
 
 
 
Impaired Mortgage Loans
 
 
 
Recorded
Investment
 
Unpaid
Principal
Balance
 
Related
Allowance
 
Average
Recorded
Investment(1)
 
Interest
Income
Recognized
 
(In Millions)
December 31, 2015:
 
 
 
 
 
 
 
 
 
With no related allowance recorded:
 
 
 
 
 
 
 
 
 
Commercial mortgage loans - other
$
46

 
$
46

 
$

 
$
15

 
$

Agricultural mortgage loans

 

 

 

 

Total
$
46

 
$
46

 
$

 
$
15

 
$

With related allowance recorded:
 
 
 
 
 
 
 
 
 
Commercial mortgage loans - other
$
63

 
$
63

 
$
(6
)
 
$
137

 
$
4

Agricultural mortgage loans

 

 

 

 

Total
$
63

 
$
63

 
$
(6
)
 
$
137

 
$
4

December 31, 2014:
 
 
 
 
 
 
 
 
 
With no related allowance recorded:
 
 
 
 
 
 
 
 
 
Commercial mortgage loans - other
$

 
$

 
$

 
$

 
$

Agricultural mortgage loans

 

 

 

 

Total
$

 
$

 
$

 
$

 
$

With related allowance recorded:
 
 
 
 
 
 
 
 
 
Commercial mortgage loans - other
$
156

 
$
156

 
$
(37
)
 
$
148

 
$
2

Agricultural mortgage loans

 

 

 

 

Total
$
156

 
$
156

 
$
(37
)
 
$
148

 
$
2


(1)
Represents a five-quarter average of recorded amortized cost.
Equity Method Investments
Included in other equity investments are limited partnership interests and investment companies accounted for under the equity method with a total carrying value of $1,363 million and $1,490 million, respectively, at December 31, 2015 and 2014. The Company’s total equity in net earnings (losses) for these limited partnership interests was $71 million, $206 million and $206 million, respectively, for 2015, 2014 and 2013.
Derivatives and Offsetting Assets and Liabilities

The Company uses derivatives as part of its overall asset/liability risk management primarily to reduce exposures to equity market and interest rate risks. Derivative hedging strategies are designed to reduce these risks from an economic perspective and are all executed within the framework of a “Derivative Use Plan” approved by the NYDFS. Operation of these hedging programs is based on models involving numerous estimates and assumptions, including, among others, mortality, lapse, surrender and withdrawal rates, election rates, fund performance, market volatility and interest rates. A wide range of derivative contracts are used in these hedging programs, including exchange traded equity, currency and interest rate futures contracts, total return and/or other equity swaps, interest rate swap and floor contracts, swaptions, variance swaps, equity options as well as repo transactions, that collectively are managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in capital markets.

Derivatives utilized to hedge exposure to Variable Annuities with Guarantee Features

The Company has issued and continues to offer certain variable annuity products with GMDB, GMIB and GIB features. The Company had previously issued certain variable annuity products with GWBL, guaranteed minimum withdrawal benefit (“GMWB”) and GMAB features (collectively, “GWBL and Other Features”). The risk associated with the GMDB feature is that under-performance of the financial markets could result in GMDB benefits, in the event of death, being higher than what accumulated policyholders’ account balances would support. The risk associated with the GMIB feature is that under-performance of the financial markets could result in the present value of GMIB benefits, in the event of annuitization, being higher than what accumulated policyholders’ account balances would support, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. The risk associated with the GIB and GWBL and Other Features is that under-performance of the financial markets could result in the GIB and GWBL and Other Features’ benefits being higher than what accumulated policyholders’ account balances would support.

For GMDB, GMIB, GIB and GWBL and Other Features, the Company retains certain risks including basis, credit spread and some volatility risk and risk associated with actual versus expected assumptions for mortality, lapse and surrender, withdrawal and contractholder election rates, among other things. The derivative contracts are managed to correlate with changes in the value of the GMDB, GMIB, GIB and GWBL and Other Features that result from financial markets movements. A portion of exposure to realized equity volatility is hedged using equity options and variance swaps and a portion of exposure to credit risk is hedged using total return swaps on fixed income indices. Additionally, the Company is party to total return swaps for which the reference U.S. Treasury securities are contemporaneously purchased from the market and sold to the swap counterparty. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. The Company has also purchased reinsurance contracts to mitigate the risks associated with GMDB features and the impact of potential market fluctuations on future policyholder elections of GMIB features contained in certain annuity contracts issued by the Company.

The Company has in place a hedge program utilizing interest rate swaps to partially protect the overall profitability of future variable annuity sales against declining interest rates.
Derivatives utilized to hedge crediting rate exposure on SCS, SIO, MSO and IUL products/investment options

The Company hedges crediting rates in the Structured Capital Strategies® (“SCS”) variable annuity, Structured Investment Option in the EQUI-VEST® variable annuity series (“SIO”), Market Stabilizer Option® (“MSO”) in the variable life insurance products and Indexed Universal Life (“IUL”) insurance products. These products permit the contract owner to participate in the performance of an index, ETF or commodity price movement up to a cap for a set period of time. They also contain a protection feature, in which the Company will absorb, up to a certain percentage, the loss of value in an index, ETF or commodity price, which varies by product segment.

In order to support the returns associated with these features, the Company enters into derivative contracts whose payouts, in combination with fixed income investments, emulate those of the index, ETF or commodity price, subject to caps and buffers.
Derivatives utilized to hedge risks associated with interest margins on Interest Sensitive Life and Annuity Contracts
Margins or “spreads” on interest-sensitive life insurance and annuity contracts are affected by interest rate fluctuations as the yield on portfolio investments, primarily fixed maturities, is intended to support required payments under these contracts, including interest rates credited to their policy and contract holders. From time to time, the Company uses interest rate swaptions and other instruments to reduce the risk associated with minimum guarantees on these interest-sensitive contracts. At December 31, 2015 and 2014, there were no positions outstanding for these programs.
Derivatives utilized to hedge equity market risks associated with the General Account’s seed money investments in Separate Accounts, retail mutual funds and Separate Account fee revenue fluctuations

The Company’s General Account seed money investments in Separate Account equity funds and retail mutual funds exposes the Company to market risk, including equity market risk, which is partially hedged through equity-index futures contracts to minimize such risk.

In second quarter 2015, the Company entered into futures on equity indices to mitigate the impact on net earnings from Separate Account fee revenue fluctuations due to movements in the equity markets. These positions partially cover fees expected to be earned through the current year from the Company’s Separate Account products.
Derivatives utilized for General Account Investment Portfolio
Beginning in the second quarter of 2013, the Company implemented a strategy in its General Account investment portfolio to replicate the credit exposure of fixed maturity securities otherwise permissible under its investment guidelines through the sale of credit default swaps (“CDSs”). Under the terms of these swaps, the Company receives quarterly fixed premiums that, together with any initial amount paid or received at trade inception, replicate the credit spread otherwise currently obtainable by purchasing the referenced entity’s bonds of similar maturity. These credit derivatives have remaining terms of five years or less and are recorded at fair value with changes in fair value, including the yield component that emerges from initial amounts paid or received, reported in Net investment income (loss). The Company manages its credit exposure taking into consideration both cash and derivatives based positions and selects the reference entities in its replicated credit exposures in a manner consistent with its selection of fixed maturities. In addition, the Company has transacted the sale of CDSs exclusively in single name reference entities of investment grade credit quality and with counterparties subject to collateral posting requirements. If there is an event of default by the reference entity or other such credit event as defined under the terms of the swap contract, the Company is obligated to perform under the credit derivative and, at the counterparty’s option, either pay the referenced amount of the contract less an auction-determined recovery amount or pay the referenced amount of the contract and receive in return the defaulted or similar security of the reference entity for recovery by sale at the contract settlement auction. To date, there have been no events of default or circumstances indicative of a deterioration in the credit quality of the named referenced entities to require or suggest that the Company will have to perform under these CDSs. The maximum potential amount of future payments the Company could be required to make under these credit derivatives is limited to the par value of the referenced securities which is the dollar-equivalent of the derivative notional amount. The Standard North American CDS Contract (“SNAC”) under which the Company executes these CDS sales transactions does not contain recourse provisions for recovery of amounts paid under the credit derivative.

Periodically, the Company purchases 30-year, Treasury Inflation Protected Securities (“TIPS”) and other sovereign inflation bonds as General Account investments and enters into asset swaps, to result in payment of the variable principal at maturity and semi-annual coupons of the bonds to the swap counterparty (pay variable) in return for fixed amounts (receive fixed). These asset swaps, when considered in combination with the bonds, together result in a net position that is intended to replicate a dollar-denominated fixed-coupon cash bond with a yield higher than a term-equivalent U.S. Treasury bond.

In third quarter of 2014, the Company implemented a strategy to hedge a portion of the credit exposure in its General Account investment portfolio by buying protection through a swap. These are swaps on the “super senior tranche” of the investment grade credit default swap index (“CDX index”). Under the terms of these swaps, the Company pays quarterly fixed premiums that, together with any initial amount paid or received at trade inception, serve as premiums paid to hedge the risk arising from multiple defaults of bonds referenced in the CDX index. These credit derivatives have remaining terms of five years or less and are recorded at fair value with changes in fair value, including the yield component that emerges from initial amounts paid or received, reported in Net investment income (loss) from derivative instruments.
The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments.
Derivative Instruments by Category
At or For the Year Ended December 31, 2015
 
 
 
Fair Value
 
 
 
Notional
Amount
 
Asset
Derivatives
 
Liability
Derivatives
 
Gains (Losses)
Reported In
Earnings (Loss)
 
(In Millions)
Freestanding derivatives:
 
 
 
 
 
 
 
Equity contracts:(1)
 
 
 
 
 
 
 
Futures
$
7,089

 
$
2

 
$
3

 
$
(84
)
Swaps
1,359

 
8

 
21

 
(45
)
Options
7,358

 
1,042

 
652

 
14

Interest rate contracts:(1)
 
 
 
 
 
 
 
Floors
1,800

 
61

 

 
12

Swaps
13,718

 
351

 
108

 
(8
)
Futures
8,685

 

 

 
(81
)
Swaptions

 

 

 
118

Credit contracts:(1)
 
 
 
 
 
 
 
Credit default swaps
2,442

 
16

 
38

 
(14
)
Other freestanding contracts:(1)
 
 
 
 
 
 
 
Foreign currency Contracts
263

 
5

 
4

 
7

Net investment income (loss)
 
 
 
 
 
 
(81
)
Embedded derivatives:
 
 
 
 
 
 
 
GMIB reinsurance contracts

 
10,570

 

 
(141
)
GIB and GWBL and other features(2)

 

 
184

 
(56
)
SCS, SIO, MSO and IUL indexed features(3)

 

 
310

 
(38
)
Balances, December 31, 2015
$
42,714

 
$
12,055

 
$
1,320

 
$
(260
)

(1)
Reported in Other invested assets in the consolidated balance sheets.
(2)
Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets.
(3)
SCS and SIO indexed features are reported in Policyholders’ account balances; MSO and IUL indexed features are reported in Future policyholders’ benefits and other policyholders’ liabilities in the consolidated balance sheets.
Derivative Instruments by Category
At or For the Year Ended December 31, 2014
 
 
 
Fair Value
 
 
 
Notional
Amount
 
Asset
Derivatives
 
Liability
Derivatives
 
Gains (Losses)
Reported In
Earnings (Loss)
 
(In Millions)
Freestanding derivatives:
 
 
 
 
 
 
 
Equity contracts:(1)
 
 
 
 
 
 
 
Futures
$
5,933

 
$
1

 
$
2

 
$
(522
)
Swaps
1,169

 
22

 
15

 
(88
)
Options
6,896

 
1,215

 
742

 
196

Interest rate contracts:(1)
 
 
 
 
 
 
 
Floors
2,100

 
120

 

 
9

Swaps
11,608

 
605

 
15

 
1,507

Futures
10,647

 

 

 
459

Swaptions
4,800

 
72

 

 
37

Credit contracts:(1)
 
 
 
 
 
 
 
Credit default swaps
1,942

 
9

 
27

 
4

Other freestanding contracts:(1)
 
 
 
 
 
 
 
Foreign currency Contracts
149

 
2

 

 
3

Net investment income (loss)
 
 
 
 
 
 
1,605

Embedded derivatives:
 
 
 
 
 
 
 
GMIB reinsurance contracts

 
10,711

 

 
3,964

GIB and GWBL and other features(2)

 

 
128

 
(128
)
SCS, SIO, MSO and IUL indexed features(3)

 

 
380

 
(199
)
Balances, December 31, 2014
$
45,244

 
$
12,757

 
$
1,309

 
$
5,242



(1)
Reported in Other invested assets in the consolidated balance sheets.
(2)
Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets.
(3)
SCS and SIO indexed features are reported in Policyholders’ account balances; MSO and IUL indexed features are reported in Future policyholders’ benefits and other policyholders’ liabilities in the consolidated balance sheets.
Equity-Based and Treasury Futures Contracts
All outstanding equity-based and treasury futures contracts at December 31, 2015 are exchange-traded and net settled daily in cash. At December 31, 2015, the Company had open exchange-traded futures positions on: (i) the S&P 500, Russell 2000, NASDAQ 100 and Emerging Market indices, having initial margin requirements of $276 million, (ii) the 2-year, 5-year and 10-year U.S. Treasury Notes on U.S. Treasury bonds and ultra-long bonds, having initial margin requirements of $33 million and (iii) the Euro Stoxx, FTSE 100, Topix, ASX 200, and European, Australasia, and Far East (“EAFE”) indices as well as corresponding currency futures on the Euro/U.S. dollar, Pound/U.S. dollar, Australian dollar/U.S. dollar, and Yen/U.S. dollar, having initial margin requirements of $49 million.
Credit Risk
Although notional amount is the most commonly used measure of volume in the derivatives market, it is not used as a measure of credit risk. A derivative with positive fair value (a derivative asset) indicates existence of credit risk because the counterparty would owe money to the Company if the contract were closed at the reporting date. Alternatively, a derivative contract with negative fair value (a derivative liability) indicates the Company would owe money to the counterparty if the contract were closed at the reporting date. To reduce credit exposures in OTC derivative transactions the Company generally enters into master agreements that provide for a netting of financial exposures with the counterparty and allow for collateral arrangements as further described below under “ISDA Master Agreements.” The Company further controls and minimizes its counterparty exposure through a credit appraisal and approval process.
ISDA Master Agreements
Netting Provisions. The standardized “ISDA Master Agreement” under which the Company conducts its OTC derivative transactions includes provisions for payment netting. In the normal course of business activities, if there is more than one derivative transaction with a single counterparty, the Company will set-off the cash flows of those derivatives into a single amount to be exchanged in settlement of the resulting net payable or receivable with that counterparty. In the event of default, insolvency, or other similar event pre-defined under the ISDA Master Agreement that would result in termination of OTC derivatives transactions before their maturity, netting procedures would be applied to calculate a single net payable or receivable with the counterparty.
Collateral Arrangements. The Company generally has executed a CSA under the ISDA Master Agreement it maintains with each of its OTC derivative counterparties that requires both posting and accepting collateral either in the form of cash or high-quality securities, such as U.S. Treasury securities, U.S. government and government agency securities and investment grade corporate bonds. These CSAs are bilateral agreements that require collateral postings by the party “out-of-the-money” or in a net derivative liability position. Various thresholds for the amount and timing of collateralization of net liability positions are applicable. Consequently, the credit exposure of the Company’s OTC derivative contracts is limited to the net positive estimated fair value of those contracts at the reporting date after taking into consideration the existence of netting agreements and any collateral received pursuant to CSAs. Derivatives are recognized at fair value in the consolidated balance sheets and are reported either as assets in Other invested assets or as liabilities in Other liabilities, except for embedded insurance-related derivatives as described above and derivatives transacted with a related counterparty. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed.
At December 31, 2015 and 2014, respectively, the Company held $655 million and $1,225 million in cash and securities collateral delivered by trade counterparties, representing the fair value of the related derivative agreements. This unrestricted cash collateral is reported in Cash and cash equivalents, and the obligation to return it is reported in Other liabilities in the consolidated balance sheets. The aggregate fair value of all collateralized derivative transactions that were in a liability position with trade counterparties December 31, 2015 and 2014, respectively, were $5 million and $28 million, for which the Company posted collateral of $5 million and $36 million at December 31, 2015 and 2014, respectively, in the normal operation of its collateral arrangements. Certain of the Company’s ISDA Master Agreements contain contingent provisions that permit the counterparty to terminate the ISDA Master Agreement if the Company’s credit rating falls below a specified threshold, however, the occurrence of such credit event would not impose additional collateral requirements.
Securities Repurchase and Reverse Repurchase Transactions
Securities repurchase and reverse repurchase transactions are conducted by the Company under a standardized securities industry master agreement, amended to suit the specificities of each respective counterparty. These agreements generally provide detail as to the nature of the transaction, including provisions for payment netting, establish parameters concerning the ownership and custody of the collateral securities, including the right to substitute collateral during the term of the agreement, and provide for remedies in the event of default by either party. Amounts due to/from the same counterparty under these arrangements generally would be netted in the event of default and subject to rights of set-off in bankruptcy. The Company’s securities repurchase and reverse repurchase agreements are accounted for as secured borrowing or lending arrangements respectively, and are reported in the consolidated balance sheets on a gross basis. The Company obtains or posts collateral generally in the form of cash, U.S. Treasury, corporate and government agency securities. The fair value of the securities to be repurchased or resold are monitored on a daily basis with additional collateral posted or obtained as necessary. Securities to be repurchased or resold are the same, or substantially the same, as those initially transacted under the arrangement. At December 31, 2015 and 2014, the balance outstanding under reverse repurchase transactions was $79 million and $0 million, respectively. At December 31, 2015 and 2014, the balance outstanding under securities repurchase transactions was $1,890 million and $950 million, respectively. The Company utilized these repurchase agreements for asset liability management purposes. For other instruments used for asset liability management purposes, see “Policyholders’ Account Balances and Future Policy Benefits” included in Note 2.

The following table presents information about the Insurance Segment’s offsetting of financial assets and liabilities and derivative instruments at December 31, 2015.
Offsetting of Financial Assets and Liabilities and Derivative Instruments
At December 31, 2015
 
Gross
Amounts
Recognized
 
Gross
Amounts
Offset in the
Balance Sheets
 
Net Amounts
Presented in the
Balance Sheets
 
(In Millions)
ASSETS(1)
 
 
 
 
 
Description
 
 
 
 
 
Derivatives:
 
 
 
 
 
Equity contracts
$
1,049

 
$
673

 
$
376

Interest rate contracts
389

 
104

 
285

Credit contracts
14

 
37

 
(23
)
Total Derivatives, subject to an ISDA Master Agreement
1,452

 
814

 
638

Total Derivatives, not subject to an ISDA Master Agreement
20

 

 
20

Total Derivatives
1,472

 
814

 
658

Other financial instruments(2) (4)
1,271

 

 
1,271

Other invested assets(2)
$
2,743

 
$
814

 
$
1,929

 
 
 
 
 
 
Securities purchased under agreement to resell
$
79

 

 
$
79


 
Gross
Amounts
Recognized
 
Gross
Amounts
Offset in the
Balance Sheets
 
Net Amounts
Presented in the
Balance Sheets
 
(In Millions)
LIABILITIES(3)
 
 
 
 
 
Description
 
 
 
 
 
Derivatives:
 
 
 
 
 
Equity contracts
$
673

 
$
673

 
$

Interest rate contracts
104

 
104

 

Credit contracts
37

 
37

 

Total Derivatives, subject to an ISDA Master Agreement
814

 
814

 

Total Derivatives, not subject to an ISDA Master Agreement

 

 

Total Derivatives
814

 
814

 

Other financial liabilities
2,586

 

 
2,586

Other liabilities
$
3,400

 
$
814

 
$
2,586

 
 
 
 
 
 
Securities sold under agreement to repurchase
$
1,890

 
$

 
$
1,890



(1)
Excludes Investment Management segment’s $13 million net derivative assets, $6 million long exchange traded options and $75 million of securities borrowed.
(2)
Includes $141 million of accrued interest related to derivative instruments reported in other assets on the consolidated balance sheets.
(3)
Excludes Investment Management segment’s $12 million net derivative liabilities, $1 million short exchange traded options and $10 million of securities loaned.
(4)
Includes margin of $(2) million related to derivative instruments.
The following table presents information about the Insurance segment’s gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2015.
Gross Collateral Amounts Not Offset in the Consolidated Balance Sheets
At December 31, 2015
 
Net Amounts
Presented in the
Balance Sheets
 
Collateral (Received)/Held
 
 
 
Financial
Instruments
 
Cash
 
Net  
Amounts  
 
(In Millions)
ASSETS(1)
 
 
 
 
 
 
 
Counterparty A
$
52

 
$

 
$
(52
)
 
$

Counterparty B
9

 

 
(7
)
 
2

Counterparty C
61

 

 
(58
)
 
3

Counterparty D
222

 

 
(218
)
 
4

Counterparty E
53

 

 
(53
)
 

Counterparty F
(2
)
 

 
2

 

Counterparty G
129

 

 
(129
)
 

Counterparty H
16

 
(11
)
 
(5
)
 

Counterparty I
44

 

 
(39
)
 
5

Counterparty J
19

 

 
(13
)
 
6

Counterparty K
17

 

 
(17
)
 

Counterparty L
7

 

 
(7
)
 

Counterparty M
11

 

 
(10
)
 
1

Counterparty N
20

 

 

 
20

Counterparty Q

 

 

 

Counterparty T
(3
)
 

 
3

 

Counterparty U

 

 
1

 
1

Counterparty V
3

 

 
(3
)
 

Total Derivatives
$
658

 
$
(11
)
 
$
(605
)
 
$
42

Other financial instruments(2) (4)
1,271

 

 

 
1,271

Other invested assets(2)
$
1,929

 
$
(11
)
 
$
(605
)
 
$
1,313

 
 
 
 
 
 
 
 
Counterparty M
$
28

 
$
(28
)
 
$

 
$

Counterparty V
51

 
(51
)
 

 

Securities purchased under agreement to resell
$
79

 
$
(79
)
 
$

 
$

 
Net Amounts
Presented in the
Balance Sheets
 
Collateral (Received)/Held
 
 
 
Financial
Instruments
 
Cash
 
Net  
Amounts  
 
(In Millions)
LIABILITIES(3)
 
 
 
 
 
 
 
Counterparty D
$
234

 
$
(234
)
 
$

 

Counterparty C
1,033

 
(1,016
)
 
(17
)
 

Counterparty M
623

 
(611
)
 
(12
)
 

Securities sold under agreement to repurchase
$
1,890

 
$
(1,861
)
 
$
(29
)
 
$


(1)
Excludes Investment Management segment’s cash collateral received of $2 million related to derivative assets and $75 million related to securities borrowed.
(2)
Includes $141 million of accrued interest related to derivative instruments reported in other assets on the consolidated balance sheets.
(3)
Excludes Investment Management segment’s cash collateral pledged of $12 million related to derivative liabilities and $10 million related to securities loaned.
(4)
Includes margin of $(2) million related to derivative instruments.



The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at December 31, 2015.

Repurchase Agreement Accounted for as Secured Borrowings(1) 
 
At December 31, 2015
 
Remaining Contractual Maturity of the Agreements
 
Overnight and
Continuous
 
Up to 30 days
 
30-90
days
 
Greater Than
90 days
 
Total
 
 
(In Millions)
Securities sold under agreement to repurchase
 
 
 
 
 
 
 
 
 
U.S. Treasury and agency securities
$

 
$
1,865

 
$
25

 
$

 
$
1,890

Total
$

 
$
1,865

 
$
25

 
$

 
$
1,890

Securities purchased under agreement to resell
 
 
 
 
 
 
 
 
 
Corporate securities
$

 
$
79

 
$

 
$

 
$
79

Total
$

 
$
79

 
$

 
$

 
$
79


(1)
Excludes Investment Management segment’s $75 million of securities borrowed.
The following table presents information about the Insurance segment’s offsetting of financial assets and liabilities and derivative instruments at December 31, 2014.
Offsetting of Financial Assets and Liabilities and Derivative Instruments
At December 31, 2014
 
Gross
Amounts
Recognized
 
Gross
Amounts
Offset in the
Balance Sheets
 
Net Amounts
Presented in the
Balance Sheets
 
(In Millions)
ASSETS(1)
 
 
 
 
 
Description
 
 
 
 
 
Derivatives:
 
 
 
 
 
Equity contracts
$
1,236

 
$
753

 
$
483

Interest rate contracts
755

 
12

 
743

Credit contracts
7

 
27

 
(20
)
Total Derivatives, subject to an ISDA Master Agreement
1,998

 
792

 
1,206

Total Derivatives, not subject to an ISDA Master Agreement
40

 

 
40

Total Derivatives
2,038

 
792

 
1,246

Other financial instruments(2)
852

 

 
852

Other invested assets(2)
$
2,890

 
$
792

 
$
2,098

 
Gross
Amounts
Recognized
 
Gross
Amounts
Offset in the
Balance Sheets
 
Net Amounts
Presented in the
Balance Sheets
 
(In Millions)
LIABILITIES(3)
 
 
 
 
 
Description
 
 
 
 
 
Derivatives:
 
 
 
 
 
Equity contracts
$
753

 
$
753

 
$

Interest rate contracts
12

 
12

 

Total Derivatives, subject to an ISDA Master Agreement
765

 
765

 

Total Derivatives, not subject to an ISDA Master Agreement

 

 

Total Derivatives
765

 
765

 

Other financial liabilities
2,939

 

 
2,939

Other liabilities
$
3,704

 
$
765

 
$
2,939

 
 
 
 
 
 
Securities sold under agreement to repurchase
$
950

 
$

 
$
950



(1)
Excludes Investment Management segment’s $8 million net derivative assets, $22 million long exchange traded options and $158 million of securities borrowed.
(2)
Includes $120 million related to accrued interest related to derivative instruments reported in other assets on the consolidated balance sheets.
(3)
Excludes Investment Management segment’s $9 million net derivative liabilities, $7 million short exchange traded options and $34 million of securities loaned.
The following table presents information about the Insurance segment’s gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2014.
Gross Collateral Amounts Not Offset in the Consolidated Balance Sheets
At December 31, 2014
 
Net Amounts
Presented in the
Balance Sheets
 
Collateral (Received)/Held
 
 
 
Financial
Instruments
 
Cash
 
Net
   Amounts  
 
(In Millions)
ASSETS(1)
 
 
 
 
 
 
 
Counterparty A
$
62

 
$

 
$
(62
)
 
$

Counterparty B
102

 

 
(95
)
 
7

Counterparty C
111

 

 
(110
)
 
1

Counterparty D
228

 

 
(224
)
 
4

Counterparty E
60

 

 
(59
)
 
1

Counterparty F
63

 

 
(60
)
 
3

Counterparty G
145

 
(145
)
 

 

Counterparty H
31

 
(31
)
 

 

Counterparty I
136

 

 
(134
)
 
2

Counterparty J
28

 

 
(22
)
 
6

Counterparty K
44

 

 
(44
)
 

Counterparty L
113

 
(113
)
 

 

Counterparty M
76

 

 
(68
)
 
8

Counterparty N
40

 

 

 
40

Counterparty Q
4

 

 
(4
)
 

Counterparty T
3

 

 
(3
)
 

Total Derivatives
$
1,246

 
$
(289
)
 
$
(885
)
 
$
72

Other financial instruments(2)
852

 

 

 
852

Other invested assets(2)
$
2,098

 
$
(289
)
 
$
(885
)
 
$
924

 
 
 
 
 
 
 
 
LIABILITIES(3)
 
 
 
 
 
 
 
Counterparty D
$
450

 
$
(450
)
 
$

 

Counterparty C
500

 
(500
)
 

 

Securities sold under agreement to repurchase
$
950

 
$
(950
)
 
$

 
$



(1)
Excludes Investment Management segment’s cash collateral received of $1 million related to derivative assets and $158 million related to securities borrowed.
(2)
Includes $120 million of accrued interest related to derivative instruments reported in other assets on the consolidated balance sheets.
(3)
Excludes Investment Management segment’s cash collateral pledged of $10 million related to derivative liabilities and $34 million related to securities loaned.
Net Investment Income (Loss)
The following table breaks out Net investment income (loss) by asset category:
 
2015
 
2014
 
2013
 
(In Millions)
Fixed maturities
$
1,420

 
$
1,431

 
$
1,462

Mortgage loans on real estate
338

 
306

 
284

Repurchase agreement
1

 

 

Other equity investments
84

 
200

 
228

Policy loans
213

 
216

 
219

Derivative investments
(81
)
 
1,605

 
(2,866
)
Trading securities
17

 
63

 
54

Other investment income
40

 
49

 
50

Gross investment income (loss)
2,032

 
3,870

 
(569
)
Investment expenses
(53
)
 
(53
)
 
(57
)
Interest expense
(3
)
 
(2
)
 
(3
)
Net Investment Income (Loss)
$
1,976

 
$
3,815

 
$
(629
)

For 2015, 2014 and 2013, respectively, Net investment income (loss) from derivatives included $474 million, $899 million and $(2,829) million of realized gains (losses) on contracts closed during those periods and $(555) million, $706 million and $(37) million of unrealized gains (losses) on derivative positions at each respective year end.
Investment Gains (Losses), Net
Investment gains (losses), net including changes in the valuation allowances and OTTI are as follows:
 
2015
 
2014
 
2013
 
(In Millions)
Fixed maturities
$
(17
)
 
$
(54
)
 
$
(75
)
Mortgage loans on real estate
(1
)
 
(3
)
 
(7
)
Other equity investments
(5
)
 
(2
)
 
(17
)
Other
3

 
1

 

Investment Gains (Losses), Net
$
(20
)
 
$
(58
)
 
$
(99
)

For 2015, 2014 and 2013, respectively, investment results passed through to certain participating group annuity contracts as interest credited to policyholders’ account balances totaled $4 million, $5 million and $8 million.